IM Cannabis (IMCC) Gains from Investment Securities (2020 - 2026)
IM Cannabis (IMCC) recorded quarterly Gains from Investment Securities of -$4375.2 in Q1 2026, down 167.79% quarter-over-quarter from $6453.8 in Q4 2025, and down 4.63% on a YoY basis from -$4587.8 in Q1 2025.
IM Cannabis (IMCC) Gains from Investment Securities (2020 - 2026) Analysis & Trends
IM Cannabis' Gains from Investment Securities history runs 7 years deep, the most recent figure standing at -$4375.2 for Q1 2026.
- In Q1 2026, Gains from Investment Securities fell 4.63% year-over-year to -$4375.2; the TTM figure through Mar 2026 stood at -$920284.8 (down 179.44% YoY), while the FY2024 annual figure was -$171643.9, changed N/A from the prior year.
- Gains from Investment Securities was -$4375.2 for Q1 2026 at IM Cannabis, down from $6453.8 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.2 million in Q4 2022 to a low of -$920183.4 in Q2 2025.
- Historically, Gains from Investment Securities has averaged -$4665.1 across 5 years, with a median of -$4181.5 in 2025.
- The sharpest annual moves came in 2022 and 2025: Gains from Investment Securities soared 160.65% in 2022, then sank 742.12% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $1.2 million in 2022, then sank by 102.38% to -$27912.4 in 2023, then slumped by 441.14% to -$151044.2 in 2024, then jumped by 104.27% to $6453.8 in 2025, then slumped by 167.79% to -$4375.2 in 2026.
- The last three Gains from Investment Securities figures came in at -$4375.2 (Q1 2026), $6453.8 (Q4 2025), and -$2179.9 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | IM Cannabis | 49,978.63 | -735,375.90 | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,375.23 |
| Mar 31, 2026 | -4,375.23 |
| Dec 31, 2025 | 6,453.78 |
| Dec 31, 2025 | 6,453.78 |
| Sep 30, 2025 | -2,179.91 |
| Sep 30, 2025 | -2,179.91 |
| Jun 30, 2025 | -920,183.44 |
| Jun 30, 2025 | -920,183.44 |
| Mar 31, 2025 | -4,181.50 |
| Mar 31, 2025 | -4,181.50 |
| Dec 31, 2024 | -151,044.17 |
| Dec 31, 2024 | -151,044.17 |
| Sep 30, 2024 | -317,412.13 |
| Sep 30, 2024 | -317,412.13 |
| Jun 30, 2024 | 143,303.55 |
| Jun 30, 2024 | 143,303.55 |
| Mar 31, 2024 | -89,795.70 |
| Mar 31, 2024 | -89,795.70 |
| Dec 31, 2023 | -27,912.35 |
| Dec 31, 2023 | -27,912.35 |